PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 124 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,000 | -92.6% | 2,078 | -81.9% | 0.00% | -100.0% |
| Q3 2021 | $81,000 | -19.8% | 11,457 | +3.8% | 0.00% | -20.0% |
| Q2 2021 | $101,000 | +1920.0% | 11,035 | +1786.3% | 0.01% | – |
| Q3 2020 | $5,000 | -66.7% | 585 | -61.7% | 0.00% | -100.0% |
| Q2 2020 | $15,000 | +87.5% | 1,529 | +64.6% | 0.00% | 0.0% |
| Q1 2020 | $8,000 | -81.4% | 929 | -81.3% | 0.00% | -66.7% |
| Q4 2019 | $43,000 | +115.0% | 4,958 | +169.6% | 0.00% | +200.0% |
| Q3 2019 | $20,000 | +122.2% | 1,839 | +168.9% | 0.00% | 0.0% |
| Q2 2019 | $9,000 | +125.0% | 684 | +564.1% | 0.00% | – |
| Q1 2019 | $4,000 | +33.3% | 103 | -26.4% | 0.00% | – |
| Q4 2018 | $3,000 | -50.0% | 140 | +12.9% | 0.00% | – |
| Q3 2018 | $6,000 | -99.9% | 124 | +61.0% | 0.00% | – |
| Q2 2018 | $4,555,000 | +12210.8% | 77 | -79.0% | 0.00% | -100.0% |
| Q4 2017 | $37,000 | +236.4% | 366 | +315.9% | 0.00% | +200.0% |
| Q3 2017 | $11,000 | +22.2% | 88 | -11.1% | 0.00% | 0.0% |
| Q2 2017 | $9,000 | +28.6% | 99 | -45.3% | 0.00% | 0.0% |
| Q1 2017 | $7,000 | -53.3% | 181 | -64.1% | 0.00% | 0.0% |
| Q4 2016 | $15,000 | – | 504 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |